655 related articles for article (PubMed ID: 35066114)
1. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
[TBL] [Abstract][Full Text] [Related]
2. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
3. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease.
Cong J; Zhou P; Zhang R
Nutrients; 2022 May; 14(9):. PubMed ID: 35565943
[TBL] [Abstract][Full Text] [Related]
5. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
7. The role of short-chain fatty acids in microbiota-gut-brain communication.
Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
[TBL] [Abstract][Full Text] [Related]
8. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.
Boets E; Gomand SV; Deroover L; Preston T; Vermeulen K; De Preter V; Hamer HM; Van den Mooter G; De Vuyst L; Courtin CM; Annaert P; Delcour JA; Verbeke KA
J Physiol; 2017 Jan; 595(2):541-555. PubMed ID: 27510655
[TBL] [Abstract][Full Text] [Related]
9. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.
Dugas LR; Lie L; Plange-Rhule J; Bedu-Addo K; Bovet P; Lambert EV; Forrester TE; Luke A; Gilbert JA; Layden BT
BMC Public Health; 2018 Aug; 18(1):978. PubMed ID: 30081857
[TBL] [Abstract][Full Text] [Related]
11. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
Silva YP; Bernardi A; Frozza RL
Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
[TBL] [Abstract][Full Text] [Related]
12. Short-Chain Fatty Acids in the Microbiota-Gut-Brain Axis: Role in Neurodegenerative Disorders and Viral Infections.
Majumdar A; Siva Venkatesh IP; Basu A
ACS Chem Neurosci; 2023 Mar; 14(6):1045-1062. PubMed ID: 36868874
[TBL] [Abstract][Full Text] [Related]
13. Short-chain fatty acids-producing probiotics: A novel source of psychobiotics.
Cheng Y; Liu J; Ling Z
Crit Rev Food Sci Nutr; 2022; 62(28):7929-7959. PubMed ID: 33955288
[TBL] [Abstract][Full Text] [Related]
14. The gut-bone axis: how bacterial metabolites bridge the distance.
Zaiss MM; Jones RM; Schett G; Pacifici R
J Clin Invest; 2019 Jul; 129(8):3018-3028. PubMed ID: 31305265
[TBL] [Abstract][Full Text] [Related]
15. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
Ohira H; Tsutsui W; Fujioka Y
J Atheroscler Thromb; 2017 Jul; 24(7):660-672. PubMed ID: 28552897
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
17. The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids.
Xiao W; Su J; Gao X; Yang H; Weng R; Ni W; Gu Y
Microbiome; 2022 Apr; 10(1):62. PubMed ID: 35430804
[TBL] [Abstract][Full Text] [Related]
18. How Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure.
Xu C; Marques FZ
Curr Hypertens Rep; 2022 Nov; 24(11):509-521. PubMed ID: 35838884
[TBL] [Abstract][Full Text] [Related]
19. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
20. The gut-lung axis in severe acute Pancreatitis-associated lung injury: The protection by the gut microbiota through short-chain fatty acids.
Wang Z; Liu J; Li F; Luo Y; Ge P; Zhang Y; Wen H; Yang Q; Ma S; Chen H
Pharmacol Res; 2022 Aug; 182():106321. PubMed ID: 35752356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
